| 标题 |
Abstract PS5-02-28: Safety analysis of phase 3 ASCENT-04 study of sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro for previously untreated PD-L1+ metastatic triple-negative breast cancer (mTNBC) |
| 网址 | |
| DOI |
10.1158/1557-3265.sabcs25-ps5-02-28
doi
|
| 其它 |
期刊:Clinical Cancer Research 作者:K. Kalinsky; P. Schmid; E. de Azambuja; S. Loi; S. Kim; et al 出版日期:2026-02-17 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)